GLP-1 agonists associated with quicker advancement of certain neurological disorders
Neurologists Issue Caution on GLP-1 Drugs and Neurodegenerative Diseases Neurologists are raising alarms about the possible adverse effects that popular weight loss medications may have on neurodegenerative diseases like ALS. Dr. Jincy Andrews, a neurologist and director at the NYU Langone ALS Center, points out that while these drugs promote quick weight loss—something that attracts […]